The global hospital gown market was valued at USD 2,070.4 million in 2020 and is projected to grow at a CAGR of 12.4% during the forecast period. Factors driving the growth of the hospital gown market include growing number of surgeries, increasing incidence of hospital acquired infections and increase in incidence of chronic diseases. Moreover, adoption of robotic surgeries may hinder the market growth.
The global hospital gown market is segmented based on type, usability and risk type. Usability is further split into disposable gowns and reusable gowns. The disposable gowns segment dominated the market in 2019. On the basis of type, the market is segmented into surgical gowns, non-surgical gowns and patient gowns. The patient gowns is projected to observer the fastest CAGR over the forecast period. By risk type, the high risk gowns segment accounted for the largest share of the global hospital gown market and is projected to sustain its dominance over the forecast period.
The global Hospital Gown market is projected to reach USD 12.8 billion by 2030, growing at a CAGR of 12.88%
Regionally, North America accounted for the largest market share of the global hospital gown market attributable to the escalation in number of healthcare workers. Leading players of the global hospital gown market include Medline Industries, Inc., Standard Textile Co., Inc., Angelica Corporation, AmeriPride Services Inc., 3M, Cardinal Health, Bellcross Industries Private Limited, Priontex, Standard Textile Co., Inc. and Sara Health Care among others.
Hospital Gown Market Scope
|Revenue forecast in 2030
|USD 12.8 billion
|CAGR of 12.88% during 2020-2030
|By Type, Regions
|North America, Europe, Asia Pacific, South America, Middle East and Africa
|Key Players Profiled
|Medline Industries, Inc., Standard Textile Co. Inc., Angelica, Ameripride Services Inc., 3M, Cardinal Health
Key segments of the global hospital gown market
Usability Overview (USD Billion)
- Disposable Gowns
- Reusable Gowns
Type Overview, (USD Billion)
- Surgical Gowns
- Non-Surgical Gowns
- Patient Gowns
Risk Type Overview, (USD Billion)
Regional Overview, (USD Billion)
- North America
- United Kingdom
- Asia Pacific
- Latin America
- Middle East & Africa
- South Africa
Reasons for the study
- Increase in number of surgeries and healthcare workers
- rising awareness about patient safety and hygiene standards
- Major market players undertaking initiatives to increase the use of hospital gowns by offering innovations and modifications
What does the report include?
- The study on the global hospital gown market includes qualitative factors such as drivers, restraints and opportunities
- The study covers qualitative and quantitative analysis of the market segmented on the basis of type, usability and risk type. Moreover, the study provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments
- The study includes the profiles of key players in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global hospital gown market is suitable for all the players across the value chain including product manufacturing companies, suppliers/distributors, R&D labs, CROs, healthcare organizations, medical reimbursement and insurance providers
- Venture capitalists and investors looking for more information on the future outlook of the global hospital gown market
- Consultants, analysts, researchers, and academicians looking for insights shaping the global hospital gown market
Frequently Asked Questions (FAQ) :
The menace of evolving infectious diseases including pandemic influenza, Ebola hemorrhagic fever, avian influenza, Hepatitis C, Hepatitis B and SARS has emphasized the requisite for effective personal protective equipment (PPE) to guard healthcare workers, patients, and visitors. PPE is a vital component in the hierarchy of controls used to defend hospital acquired infections from infectious dangers. PPE includes respirators, gowns, face masks, eye protection, gloves, face shields and head and shoe coverings. Significant research has been led in certain areas, such as respirators and protective masks, but studies in other areas, mainly gowns, are scarce. Gowns are known as the second-most-used piece of PPE, after gloves, in the healthcare setting. As per the Centers for Disease Control and Prevention’s Guideline for Isolation Precautions, isolation gowns should be worn to protect healthcare workers arms and visible body areas throughout procedures and patient-care doings when getting ahead contact with clothing, bodily fluids, blood, secretions and excretions. Isolation gowns presently offered on the market propose varying resistance to blood and other bodily fluids liable to the type of the material, its impenetrability, and wear and tear. Routine use of isolation gowns, reveal that its use is linked to a reduced infection rate.
On the basis of type, the surgical gowns dominated the market in 2019 and is also projected to retain its position by 2028.
The surgical gown acts as a key obstacle against disease spread. Surgical gowns must prevent diseases and infections yet offer suitable liberty to move. They must permit essential flexibility without irritation and resistance, and must repel tearing and linting. As there is usually additional fabric, the gowns must endure continuous pulls on the textile through mundane activities. The gowns must protect the bacteria released into the theater and help in retaining sterile zone vital for patient protection. Gowns must be sturdy enough to last the proposed useful life of the apparel, be that single or multi-use. They should also deter fluids but ventilate the doctor’s extreme body heat.
North America dominated the market for hospital gowns in 2019. In the U.S., disposable isolation gowns are used more frequently, whereas in Europe the share of reusable is bigger. About 80% of hospitals in the U.S. use single-use gowns. In the U.S. isolation gowns, that are envisioned for use in averting disease in healthcare are deliberated as medical devices, and are subject to regulation. The PPE used by healthcare workers is subjected to FDA approval in the U.S. They are regarded as Class I (general controls) devices by FDA. Class I devices with isolation gowns are deliberated as low risk to the wearers and typically excused from the premarket notification requirements. The simple requirement for isolation gowns is that the producer meets overall criteria for good manufacturing processes.